freedomdiagnosticstesting.com publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
Label 70 mg · Lab measured 59.43 mg
85% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 14.9 mg using the measured mass, against 17.5 mg on the label — 15% less.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of GHK-Cu/BPC-157/Thymosin Beta-4 from NextGen Peptides, performed by freedomdiagnosticstesting.com on December 12, 2025. Reported purity: 99.6%. Net content: 59.43 mg against 70 mg labeled (85% of label). Tested content is 15% below the labeled amount. Batch GLW4760. Sample source: shop-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| GHK-12 | 21 Apr 2026 | ILS Laboratories | 99.89% | 105% | Unverified |
| GHPV01 | 27 Feb 2026 | freedomdiagnosticstesting.com | 99.091% | 100% | Unverified |
| GHK08 | 16 Jan 2026 | Janoshik Labs | 99.693% | 120% | Unverified |
| KLW7198 | 12 Dec 2025 | freedomdiagnosticstesting.com | 99.682% | 62% | Unverified |
| GLW4760 | 12 Dec 2025 | freedomdiagnosticstesting.com | 99.6% | 100% | Unverified |
| GHKC08 | 8 Nov 2025 | freedomdiagnosticstesting.com | 99.926% | 107% | Unverified |
| GHK07 | 10 Sept 2025 | BioRegen | 99.85% | 106% | Unverified |
| AIJKO1 | 12 Jan 2025 | freedomdiagnosticstesting.com | 99.359% | 100% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion